Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2000 1
2001 5
2003 2
2004 3
2005 2
2006 1
2008 6
2009 6
2010 4
2011 6
2012 5
2013 4
2014 3
2015 9
2016 2
2018 2
2019 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
IL-11 in multiple sclerosis.
Zhang X, Putoczki T, Markovic-Plese S. Zhang X, et al. Among authors: markovic plese s. Oncotarget. 2015 Oct 20;6(32):32297-8. doi: 10.18632/oncotarget.6027. Oncotarget. 2015. PMID: 26452137 Free PMC article. No abstract available.
Pathogenic features of CD4+CD28- T cells in immune disorders.
Broux B, Markovic-Plese S, Stinissen P, Hellings N. Broux B, et al. Among authors: markovic plese s. Trends Mol Med. 2012 Aug;18(8):446-53. doi: 10.1016/j.molmed.2012.06.003. Epub 2012 Jul 10. Trends Mol Med. 2012. PMID: 22784556 Review.
Immunopathogenesis of the multiple sclerosis lesion.
Markovic-Plese S, McFarland HF. Markovic-Plese S, et al. Curr Neurol Neurosci Rep. 2001 May;1(3):257-62. doi: 10.1007/s11910-001-0028-4. Curr Neurol Neurosci Rep. 2001. PMID: 11898527 Review.
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Johnson BM, Uchimura T, Gallovic MD, Thamilarasan M, Chou WC, Gibson SA, Deng M, Tam JW, Batty CJ, Williams J, Matsushima GK, Bachelder EM, Ainslie KM, Markovic-Plese S, Ting JP. Johnson BM, et al. Among authors: markovic plese s. J Immunol. 2021 May 1;206(9):2015-2028. doi: 10.4049/jimmunol.2001317. Epub 2021 Apr 5. J Immunol. 2021. PMID: 33820855 Free PMC article.
60 results